DexCom, Inc. (NASDAQ:DXCM – Get Rating) was the target of a significant increase in short interest in April. As of April 30th, there was short interest totalling 12,730,000 shares, an increase of 5.4% from the April 15th total of 12,080,000 shares. Based on an average trading volume of 2,350,000 shares, the short-interest ratio is presently […]
Brown Brothers Harriman & Co. increased its holdings in DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 145.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,973 shares of the medical device company’s stock after acquiring an additional 2,944 shares […]
Cambridge Investment Research Advisors Inc. increased its position in shares of DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 16.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 25,280 shares of the medical device company’s stock after acquiring an additional 3,656 shares during the […]
Impax Asset Management Group plc lifted its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 18.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 331,229 shares of the medical device company’s stock after acquiring an additional […]
Russell Investments Group Ltd. boosted its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Get Rating) by 45.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 124,875 shares of the medical device company’s stock after buying an additional 39,295 […]